🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationFDA June 2026 enforcement update — compounding pharmacies Page 14

FDA June 2026 enforcement update — compounding pharmacies

RegAffairsDC Mon, Feb 26, 2024 at 4:00 PM 366 replies 55,812 viewsPage 14 of 20
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 7, 2025 at 12:04 PM#66

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source.

36 11PedsEndoPhilly, SleepDoc_PDX, RegAffairsDC and 33 others
Reply Quote Save Share Report
pete_RVA
Member
178
890
Dec 2024
Richmond, VA
Mar 15, 2025 at 3:46 AM#67
RegAffairsDC said:
I did not do what was suggested, I did something adjacent, and it worked; posting the difference in case it matters to somebody.

This matches mine closely enough to be worth saying so out loud. I had assumed I was the exception until I read this.

35 10Dr.Martinez, mike_mod, SarahChen_PharmD and 32 others
Reply Quote Save Share Report
SurmountFan_IN
Member
789
3,456
May 2024
Indianapolis, IN
Mar 22, 2025 at 7:24 PM#68
RegAffairsDC said:
I did not do what was suggested, I did something adjacent, and it worked; posting the difference in case it matters to somebody.

Coming at RegAffairsDC’s question from a different direction. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

34 9traveltech_sara, AttorneyGrant, DebRD_ATL and 31 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Mar 30, 2025 at 10:57 AM#69

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

Last edited: Mar 30, 2025 at 1:57 PM
33 8jennifer_SEA, tyler_CSCS, VanRx_Mike and 30 others
Reply Quote Save Share Report
pam_stl
Member
267
1,123
Oct 2024
St. Louis, MO
Apr 7, 2025 at 2:26 AM#70

One thing that is still open after RegAffairsDC’s answer:

What did you change at the same time, and can you separate the two now?

Last edited: Apr 7, 2025 at 7:26 AM
11 11RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 8 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register